Glutamine supplementation is supposed to reduce mortality and nosocomial infections in critically ill
patients. However, the recently published reducing deaths due to oxidative stress (REDOX) trials did not provide
evidence supporting this. This study investigated the impact of glutamine-supplemented nutrition on the outcomes of
critically ill patients using a meta-analysis.